Vaxtex Cotfab Ltd

As of June 30, 2026, Vaxtex Cotfab Ltd carries a market capitalization of 251.74M, placing it among publicly traded companies globally. Its enterprise value stands at 251.74M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Vaxtex Cotfab Ltd has 183.75M shares outstanding.

As of June 30, 2026, Vaxtex Cotfab Ltd trades at a trailing price-to-earnings ratio of 5.12.

As of June 30, 2026, Vaxtex Cotfab Ltd trades at an EV/EBITDA multiple of 13.06 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.83 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 13.16 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 251.74M versus a market cap of 251.74M, with the gap driven by net debt and cash on the balance sheet.

These figures are as of June 30, 2026.

These figures cover the twelve months ended June 30, 2026. The company generates approximately 14.80M in revenue per employee across its workforce of 6.00, a quick read on workforce productivity versus industry peers.

Over the twelve months ended June 30, 2026, Vaxtex Cotfab Ltd recorded an income tax benefit of -5.05M rather than an expense, typically from losses, carryforwards, or the release of a tax provision. Taxes are levied on pretax income of 43.94M, leaving 48.99M in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Vaxtex Cotfab Ltd's stock has gained approximately 49.49% over the past 52 weeks. The 50-day moving average sits at 1.65, while the 200-day moving average is 1.62.

Over the twelve months ended June 30, 2026, Vaxtex Cotfab Ltd generated 88.80M in revenue and converted that into 48.99M in net income, yielding earnings per share of 0.27. EBITDA reached 19.27M, while operating income came in at 19.13M.

Over the twelve months ended June 30, 2026, Vaxtex Cotfab Ltd posted a gross margin of 27.63, reflecting its pricing power and cost economics. The operating margin of 21.54 and net profit margin of 55.17 provide insight into operational efficiency.

Vaxtex Cotfab Ltd's most recent stock split took place on July 24, 2023 with a 134:141 split ratio.